Condition
Drug Administration Schedule
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 2 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04478838Phase 4Recruiting
"Extended" (Alternate Day) Antipsychotic Dosing
NCT00033085Phase 2Completed
Ondansetron for the Treatment of Cocaine Dependence - 1
NCT00033046Phase 1Unknown
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1
NCT00032916Phase 1Unknown
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
Showing all 4 trials